A 6-month, open-label extension to a 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin� LA in the treatment of adult patients with childhood-onset ADHD
Read time: 1 mins
Last updated:5th May 2011
To evaluate the long-term safety of Ritalin LA administered once daily for six months during open-label treatment in adults with ADHD.
|Study start date||2011-05-05|